French-owned Hungarian pharmaceutical company Egis Gyógyszergyár Plc. is set to implement another large-scale investment to boost efficiency and capacity at its base in Körmend, the Hungarian Investment Promotion Agency (HIPA) reports. The EUR 37.5 million investment include the modernisation of the a tableting plant and the galenic plant, and the extension of the storage facility […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that “understanding and supporting the Hungarian government's efforts to reduce the burden on patients, voluntarily restricts the price of its non-prescription product Panangin®, a magnesium and potassium dietary supplement and complementary treatment for chronic heart disease and cardiac […]
Goodwill Pharma Plc. significantly increased its net sales revenue last year by 27% compared to the previous year, with the company's after-tax profit amounting to HUF 2.155 billion, compared to HUF 1.502 billion a year earlier, according to the consolidated report published by the Szeged-based pharmaceutical company on the BSE website. According to the balance […]
Hungary continues to strengthen its position in the pharmaceutical industry as Singapore-based Hongene Biotech has announced the establishment of its first European manufacturing facility in Gödöllő, just east of Budapest. The nearly EUR 94 million greenfield investment will create 150 new jobs and contribute significantly to Hungary’s export performance, according to the Hungarian Investment Promotion […]
Budapest-based pharmaceutical company Gedeon Richter Plc. has received positive opinion from CHMP for marketing authorization for Junod and Yaxwer, its biosimilar denosumab products for bone disease and osteoporosis. Budapest-based pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it received a positive opinion from the Committee for Medicinal […]
At the Sanofi Pharmaceutical Innovation Center, the biopharmaceutical company is now presenting its global immunology strategy, highlighting the role of innovative medicines and vaccines in the future of medicine. First unveiled at the 2024 Olympic and Paralympic Games in Paris, the Sanofi Science Lab will now be the only one in Central Europe to be […]
Budapest-based pharmaceutical giant Gedeon Richter Plc. announced its Q4/FY 2024 financial results at the website of the Budapest Stock Exchange by stating that 2024 was an active year with business development across all segments, aimed at providing access to health by bringing solutions to unmet needs and by offering affordable medicines to a wide range […]
Hungary's Goodwill Pharma Plc. has expanded its warehouse capacity, built a research and development and innovation laboratory, a new head office and a pharmaceutical manufacturing plant in Szeged, Hungary, the almost HUF 5 billion investment was handed over on Thursday. Ferenc Jójárt, CEO of the Szeged-based company, said at the ceremony that Goodwill Pharma is […]
Gedeon Richter has announced positive topline results from Phase I and Phase III clinical studies for its proposed biosimilar to RoActemra® tocilizumab that has the development code 'RGB-19'. The Hungarian pharmaceutical firm points out in a statement on the webiste of the Budapest Stock Exchange that Phase I clinical study evaluated the equivalence of pharmacokinetics […]
Egis Pharmaceuticals Plc. has acquired one of Teva Pharmaceuticals Plc.'s well-known product family for skin application, following the approval of the competition authority, the pharmaceutical manufacturer informed MTI on Monday. According to the statement, the takeover of the distribution and promotion of the product line began on December 17, 2024, and the parties sought to […]
Gedeon Richter Plc. and Hikma Pharmaceuticals Plc. has announced that the U.S. Food and Drug Administration (FDA) had accepted for review the Biologics License Applications (BLA) for RGB-14, a Denosumab biosimilar candidate comprising two biosimilar products referencing Prolia® and Xgeva®, a human monoclonal antibody for the treatment of osteoporosis and fractures due to bone metastasis, […]
As part of its commitment to expanding its presence in Hungary, global animal vaccine producer Ceva-Phylaxia has announced an EUR 75 million investment, establishing a state-of-the-art unit in Monor dedicated to manufacturing inactivated, multicomponent vaccines, the Hungarian Investment Promotion Agency (HIPA) reports. Following the official groundbreaking ceremony for the 7,000-square-meter facility, production is expected to […]
The pharma companies AbbVie (headquartered in North Chicago, Illinois in the United States) and Gedeon Richter Plc. (headquartered in Budapest, Hungary) have announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions. A statement on the website of the Budapest Stock Exchange highlights that this collaboration […]
The new headquarters of Richter Plc. in Kőbánya, the 10th district of the Hungarian capital was inaugurated on Thursday. The 17,400-square-meter building, which provides space for 450 employees, was completed with an investment of HUF 20 billion, financed by the pharmaceutical company from its own resources. Speaking at the opening ceremony, Energy Minister Csaba Lantos […]
The consolidated sales revenue of the pharmaceutical company Gedeon Richter Plc. was HUF 203.4 billion in the first quarter of 2024, 3.0% lower than a year earlier, the pharmaceutical company announced on the website of the Budapest Stock Exchange (BSE) on Tuesday. Analysts had expected revenues to fall 3.6% to HUF 202 billion. In the […]
